This interrupted time-series analysis evaluated the clinical implications of switching high-sensitivity cardiac troponin assays, showing that assay changes affect diagnostic rates and patient management in acute care.
This interrupted time-series study investigates the clinical and health system–level implications of changing high-sensitivity cardiac troponin assays in patients with acute coronary syndrome (ACS).
